Lixte Biotechnology Holdings, Inc. (LIXT)

Market Cap	11.55M
Revenue (ttm)	n/a
Net Income (ttm)	-6.71M
Shares Out	16.65M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,910
Open	0.67
Previous Close	0.694
Day's Range	0.67 - 0.69
52-Week Range	0.43 - 4.95
Beta	-0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2022

About LIXT

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically ac...

• Industry: Biotechnology
• Founded: 2005
• Employees: 3
• Stock Exchange: NASDAQ
• Ticker Symbol: LIXT